1. Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. (April 2022) Authors: Coles, Alasdair J; Jones, Joanne L; Vermersch, Patrick; Traboulsee, Anthony; Bass, Ann D; Boster, Aaron; Chan, Andrew; Comi, Giancarlo; Fernández, Óscar; Giovannoni, Gavin; Kubala Havrdova, Eva; LaGanke, Christopher; Montalban, Xavier; Oreja-Guevara, Celia; Piehl, Fredrik; Wiendl, Heinz; Ziemssen... Journal: Multiple sclerosis Issue: Volume 28:Number 5(2022) Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies. (November 2020) Authors: Van Wijmeersch, Bart; Singer, Barry A; Boster, Aaron; Broadley, Simon; Fernández, Óscar; Freedman, Mark S; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Steingo, Brian; Wiendl, Heinz; Wray, Sibyl; Ziemssen, Tjalf; Chung, Luke; Margolin, David H; Thangavelu, Karthinathan; Ver... Journal: Multiple sclerosis Issue: Volume 26:Number 13(2020) Page Start: 1719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intracerebral haemorrhage during alemtuzumab administration. Issue 4 (April 2019) Authors: Azevedo, Christina J; Kutz, Christen; Dix, Amy; Boster, Aaron; Sanossian, Nerses; Kaplan, Jeffrey Journal: Lancet neurology Issue: Volume 18:Issue 4(2019) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lymphopenia and DMTs for relapsing forms of MS: Considerations for the treating neurologist. Issue 1 (February 2019) Authors: Fox, Edward J.; Buckle, Guy J.; Singer, Barry; Singh, Vibhuti; Boster, Aaron Journal: Neurology Issue: Volume 9:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial. Issue 11 (21st March 2014) Authors: Olsson, Tomas; Boster, Aaron; Fernández, Óscar; Freedman, Mark S; Pozzilli, Carlo; Bach, Doris; Berkani, Ouali; Mueller, Markus S; Sidorenko, Tatiana; Radue, Ernst-Wilhelm; Melanson, Maria Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 85:Issue 11(2014) Page Start: 1198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO152 Alemtuzumab efficacy in patients with relapse after course 1. (1st December 2017) Authors: Sharrack, Basil; Singer, Barry; Wiendl, Heinz; Broadley, Simon; Freedman, Mark S; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Steingo, Brian; Boster, Aaron Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Poster 67 Best Practices in Intrathecal Baclofen Therapy: Dosing and Long‐Term Management. Issue 9 (8th September 2015) Authors: Saulino, Michael; Adair, Roy L.; Gooch, Judith l.; Nelson, Mary Elizabeth S.; Toomer, Andrea P.; Urquidez, Jose; Boster, Aaron Journal: PM&R Issue: Volume 7:Issue 9(2015)Supplement Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. Issue 4 (December 2020) Authors: Horáková, Dana; Boster, Aaron; Bertolotto, Antonio; Freedman, Mark S; Firmino*, Isabel; Cavalier, Steven J; Jacobs*, Alan K; Thangavelu*, Karthinathan; Daizadeh, Nadia; Poole*, Elizabeth M; Baker, Darren P; Margolin*, David H; Ziemssen, Tjalf Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 6:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Toward Precision Phenotyping of Multiple Sclerosis. Issue 6 (30th November 2022) Authors: Pitt, David; Lo, Chih Hung; Gauthier, Susan A.; Hickman, Richard A.; Longbrake, Erin; Airas, Laura M.; Mao-Draayer, Yang; Riley, Claire; De Jager, Philip Lawrence; Wesley, Sarah; Boster, Aaron; Topalli, Ilir; Bagnato, Francesca; Mansoor, Mohammad; Stuve, Olaf; Kister, Ilya; Pelletier, Daniel; Sta... Journal: Neurology Issue: Volume 9:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗